Rain Oncology Long Term Debt

Rain Oncology (RAIN) currently reports a long-term debt of $72K as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Rain Oncology's long-term debt history and peer comparisons.

Rain Oncology's long-term debt changed from $0 to $72K (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Rain Oncology reported $72K in long-term debt as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $72K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Rain Oncology, and consider following RAIN for alerts when major investors trade the stock.

Rain Oncology is classified in the Healthcare sector. On long-term debt, it currently shows $72K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RAIN with unrelated industries.